Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Impact of Neuropathic Post-Zosterian Pain on the Cognition

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University Hospital, Clermont-Ferrand
ClinicalTrials.gov Identifier:
NCT00989040
First received: March 13, 2009
Last updated: January 26, 2012
Last verified: January 2012

March 13, 2009
January 26, 2012
March 2009
June 2009   (final data collection date for primary outcome measure)
The principal outcome is to explore if the cognition is failed in treated patients suffering of neuropathic post-zosteria pain. [ Time Frame: at day 1 ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT00989040 on ClinicalTrials.gov Archive Site
Study if treated patients with patch (Versatis®) have better cognition than treated patients without patch. [ Time Frame: at day 1 ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
Impact of Neuropathic Post-Zosterian Pain on the Cognition
Impact of Neuropathic Post-zosterian Pain on the Cognition (NPZ and Cognition)

Pain is defined as a sensorial and emotional phenomenon and lead consequences on the cognition. These consequences could be increased with usual treatment. So the aim of this study is to explore these cognitive consequences.

Pilot prospective study with parallel groups

Observational
Observational Model: Case Control
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample

Patients who suffer of neuropathic post-zosteria pain

  • Neuropathic Post-zosterian Pain
  • Cognition
Drug: usual treatment: Versatis
  • To explore if the cognition is failed in treated patients suffering of neuropathic postzosteria pain.
  • To see if treated patients with patch (Versatis®) have better cognition than treated patients without patch.
Not Provided
Pickering G, Pereira B, Clère F, Sorel M, de Montgazon G, Navez M, Picard P, Roux D, Morel V, Salimani R, Adda M, Legout V, Dubray C. Cognitive function in older patients with postherpetic neuralgia. Pain Pract. 2014 Jan;14(1):E1-7. doi: 10.1111/papr.12079. Epub 2013 May 23.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
100
September 2009
June 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patient suffering of NPZ pain
  • Over 55 years old
  • Healthy volunteers
Both
55 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
France
 
NCT00989040
CHU-0049
Not Provided
University Hospital, Clermont-Ferrand
University Hospital, Clermont-Ferrand
Not Provided
Principal Investigator: Claude Dubray, PUPH CIC-CPC Clermont-Ferrand
University Hospital, Clermont-Ferrand
January 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP